Literature DB >> 13907411

Studies of live attenuated measles virus vaccine in man. II. Appraisal of efficacy.

M R HILLEMAN, J STOKES, E B BUYNAK, R WEIBEL, R HALENDA, H GOLDNER.   

Abstract

Entities:  

Keywords:  MEASLES/immunology

Mesh：

Substances：

Year:  1962        PMID： 13907411      PMCID： PMC1522574          DOI： 10.2105/ajph.52.suppl_2.44

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN： 0002-9572


× No keyword cloud information.
  9 in total

1.  Use of living attenuated measles-virus vaccine in early infancy.

Authors:  J STOKES; C M REILLY; M R HILLEMAN; E B BUYNAK
Journal:  N Engl J Med       Date:  1960-08-04       Impact factor: 91.245

2.  Clinical and immunological response to live tissue culture vaccine against measles.

Authors:  A A SMORODINTSEV; L M BOICHUK; E S SHIKINA; T B BATANOVA; L V BYSTRYAKOVA; T V PERADZE
Journal:  Acta Virol       Date:  1960-07       Impact factor: 1.162

3.  Living attenuated measles-virus vaccine in early infancy. Studies of the role of passive antibody in immunization.

Authors:  C M REILLY; J STOKES; E B BUYNAK; H GOLDNER; M R HILLEMAN
Journal:  N Engl J Med       Date:  1961-07-27       Impact factor: 91.245

4.  Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination.

Authors:  J F ENDERS; S L KATZ; M V MILOVANOVIC; A HOLLOWAY
Journal:  N Engl J Med       Date:  1960-07-28       Impact factor: 91.245

5.  Studies on an attenuated measles-virus vaccine. VI. Clinical, antigenic and prophylactic effects of vaccine in institutionalized children.

Authors:  S KRUGMAN; J P GILES; A M JACOBS
Journal:  N Engl J Med       Date:  1960-07-28       Impact factor: 91.245

6.  Studies on an attenuated measles-virus vaccine. II. Clinical, virologic and immunologic effects of vaccine in institutionalized children.

Authors:  S L KATZ; J F ENDERS; A HOLLOWAY
Journal:  N Engl J Med       Date:  1960-07-28       Impact factor: 91.245

7.  Studies on an attenuated measles-virus vaccine. VIII. General summary and evaluation of the results of vaccine.

Authors:  S L KATZ; C H KEMPE; F L BLACK; M L LEPOW; S KRUGMAN; R J HAGGERTY; J F ENDERS
Journal:  N Engl J Med       Date:  1960-07-28       Impact factor: 91.245

8.  Experimental vaccination against measles. II. Tests of live measles and live distemper vaccine in human volunteers during a measles epidemic in Panama.

Authors:  M T HOEKENGA; A J SCHWARZ; H CARRIZO PALMA; P A BOYER
Journal:  J Am Med Assoc       Date:  1960-06-25

9.  Propagation in tissue cultures of cytopathogenic agents from patients with measles.

Authors:  J F ENDERS; T C PEEBLES
Journal:  Proc Soc Exp Biol Med       Date:  1954-06
  9 in total
  3 in total

1.  A collaborative study of measles vaccines in five United States communities. Preliminary report.

Authors:  V F GUINEE
Journal:  Am J Public Health Nations Health       Date:  1963-04

2.  Vaccine failures in the epidemiology and control of measles.

Authors:  M A Strassburg; S Greenland; S L Fannin
Journal:  Am J Public Health       Date:  1979-10       Impact factor: 9.308

3.  Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial.

Authors:  Yves Gillet; Pirmin Habermehl; Stéphane Thomas; Cécile Eymin; Anne Fiquet
Journal:  BMC Med       Date:  2009-04-14       Impact factor: 8.775
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.